{"id":3790,"count":5,"description":"Hypotyreos \u2014 en underaktiv sk\u00f6ldk\u00f6rtel \u2014 drabbar ungef\u00e4r 5% av vuxna v\u00e4rlden \u00f6ver<\/strong>, med kvinnor diagnostiserade fem till tio g\u00e5nger oftare \u00e4n m\u00e4n. Sk\u00f6ldk\u00f6rteln sitter framtill i halsen och producerar tv\u00e5 hormoner: tyroxin (T4)<\/strong> och trijodtyronin (T3)<\/strong>, som tillsammans reglerar \u00e4mnesoms\u00e4ttningen i varje cell i kroppen. N\u00e4r k\u00f6rteln sviktar \u2013 oftast p\u00e5 grund av autoimmun f\u00f6rst\u00f6relse (Hashimotos tyreoidit), kirurgi f\u00f6r knutor eller cancer, radiojodbehandling, medf\u00f6dd fr\u00e5nvaro eller sv\u00e5r jodbrist \u2013 upptr\u00e4der symptom gradvis: tr\u00f6tthet, vikt\u00f6kning, k\u00e4nslighet f\u00f6r kyla, f\u00f6rstoppning, torr hud, h\u00e5ravfall, depression och dimmig hj\u00e4rna. Obotad hypotyreos under graviditet \u00f6kar risken f\u00f6r missfall och f\u00f6rs\u00e4mrar fostrets neuroutveckling. Diagnosen st\u00e4lls biokemiskt: en f\u00f6rh\u00f6jd tyreoideastimulerande hormon (TSH)<\/strong> med en l\u00e5g eller l\u00e5g-normal fritt T4<\/strong>.\n\nTreatment is hormone replacement. The first-line drug is levotyroxin<\/strong> — synthetic T4 — taken once daily on an empty stomach. Levothyroxine has a long half-life (~7 days) which produces smooth blood levels with simple once-daily dosing. The body converts T4 to the more active T3 in peripheral tissues exactly as it does with the natural hormone, which is why most patients feel completely well on T4 alone. Dose is titrated against TSH every 6–8 weeks until the level sits in the target range (usually 0.5–2.5 mIU\/L), then monitored annually.\n\nLevothyroxine (T4) brands stocked at MedsBase\nAll four brands below contain the identical active ingredient — levotyroxinnatrium<\/strong>. De skiljer sig \u00e5t i tillverkare, hj\u00e4lp\u00e4mnen och prisniv\u00e5. N\u00e4r din TSH \u00e4r stabil p\u00e5 ett m\u00e4rke, undvik att byta f\u00f6r att undvika sm\u00e5 bioekvivalensvariationer som kan flytta TSH utanf\u00f6r m\u00e5let.\n\nEltroxin<\/strong><\/a> \u2014 GlaxoSmithKline (GSK), 100 mcg tablett. Globalt erk\u00e4nt m\u00e4rke som anv\u00e4nts sedan 1960-talet; samma molekyl som Synthroid och Levoxyl.\nThyronorm<\/strong><\/a> \u2014 Abbott India, full titreringsintervall 25\/50\/100\/125\/150 mcg. Den mest f\u00f6reskrivna levotyroxinen i Indien.\nThyrox<\/strong><\/a> \u2014 Macleods Pharmaceuticals, 25\/100\/125\/200 mcg. Inkluderar den h\u00f6gre 200 mcg-styrkan som \u00e4r anv\u00e4ndbar f\u00f6r TSH-suppression efter tyreoidektomi.\nL-Thyroid<\/strong><\/a> — budget option, full 25 to 150 mcg titration range.\n\n\nLiothyronine (T3) — second-line\nLiothyronin 25 mcg<\/strong><\/a> is synthetic T3 — about four times more potent than levothyroxine, with a much shorter half-life (~24 hours). Liothyronine bypasses the T4-to-T3 conversion step entirely. Its place in therapy is narrow:\n\nA liten till\u00e4ggsdos tillsammans med levotyroxin<\/strong> in selected patients with persistent hypothyroid symptoms despite a normal TSH on T4 monotherapy — usually a specialist endocrinology decision after other causes are excluded.\nShort-term f\u00f6rberedelse f\u00f6r sk\u00f6ldk\u00f6rtelcancerskanningar<\/strong> (m\u00f6jligg\u00f6r snabbare TSH-stegring efter avbrott).\nMyx\u00f6demkoma<\/strong> in hospital, given intravenously alongside T4.\nOff-label augmentation in behandlingsresistent depression<\/strong>.\n\nLiothyronine is inte<\/strong> a wholesale replacement for levothyroxine and is not a weight-loss drug — misuse in euthyroid people causes atrial fibrillation, bone loss and muscle wasting. The Cochrane systematic review found no consistent benefit of T4+T3 over T4 monotherapy for routine quality-of-life improvement.\n\nThyroid nutritional support — not a treatment substitute\nThyropace<\/strong><\/a> \u00e4r ett kosttillskott i kapselform med L-tyrosin och jod. Det ing\u00e5r i denna kategori eftersom det st\u00f6djer sk\u00f6ldk\u00f6rtelns funktion n\u00e4ringsriktigt, men det \u00e4r inte<\/strong> a substitute for levothyroxine in diagnosed hypothyroidism. Thyropace can be appropriate for confirmed mild iodine deficiency or as adjunct nutritional support during pregnancy. It should be avoided in autoimmune Hashimoto’s thyroiditis, Graves’ disease, and before radioiodine scanning — excess iodine flares autoimmunity and complicates radio-tracer imaging.\n\nCritical absorption rules for any T4 or T3 product\nLevothyroxine and liothyronine absorption are dramatically reduced by food, coffee, soy and several common medications. The rules below are essential, not optional:\n\nTake on an tom mage<\/strong>, first thing in the morning, with plain water.\nWait 30\u201360 minuter<\/strong> before any food, coffee or other tablet.\nSeparate from kalcium, j\u00e4rn, magnesium, zink, aluminium<\/strong> supplements \/ antacids by at least 4 hours.\nSeparate from protonpumpsh\u00e4mmare<\/strong> (omeprazole, esomeprazole, pantoprazole) — gastric acid is needed for full absorption.\nSeparate from kolestyramin, sevelamer, orlistat<\/strong> med minst 4 timmars mellanrum.\nGraviditet:<\/strong> behovet av levotyroxin \u00f6kar med 25\u201350% vid mitten av graviditeten \u2014 kontrollera TSH var 4:e vecka under f\u00f6rsta halvan av graviditeten.\n\u00c4ldre\/hj\u00e4rtpatienter:<\/strong> start low (25–50 mcg) and titrate slowly to avoid triggering ischaemia or atrial fibrillation.\n\n\nEvery product in this category is dispatched from a WHO-GMP-certifierad tillverkare<\/strong>, FDA-godk\u00e4nt generiskt l\u00e4kemedel d\u00e4r till\u00e4mpligt, med diskret f\u00f6rpackning och v\u00e4rldsomsp\u00e4nnande leverans. Varje produktsida inneh\u00e5ller en TSH-titreringstabell, fullst\u00e4ndig lista \u00f6ver l\u00e4kemedelsinteraktioner, biverkningsprofil vid \u00f6ver- vs underbehandling samt ett handplockat panel med alternativa preparat.","link":"https:\/\/medsbase.com\/sv\/underactive-thyroid-treatment\/","name":"Behandling av underaktiv sk\u00f6ldk\u00f6rtel","slug":"underactive-thyroid-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat\/3790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/sv\/wp-json\/wp\/v2\/product?product_cat=3790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}